References
Beauchamp, T, H.R. Ferdowsian, and J.P. Gluck. 2014. Rethinking the ethics of research involving nonhuman animals. Special issue. Theoretical Medicine and Bioethics 38(2): 91–185.
Choe Smith, C.U. 2014. Confronting ethical permissibility in animal research: Rejecting a common assumption and extending a principle of justice. Theoretical Medicine and Bioethics 35(2): 175–185.
Platt, J.R. 1964. Strong inference: Certain systematic methods of scientific thinking may produce much more rapid progress than others. Science 146(3642): 347–353.
LaFollette, H., and N. Shanks. 1996. Brute science: Dilemmas of animal experimentation. London: Routledge.
Greek, R., and N. Shanks. 2009. FAQs about the use of animals in science: A handbook for the scientifically perplexed. Lanham: University Press of America.
Greek, R., and N. Shanks. 2011. Complex systems, evolution, and animal models. Studies in History and Philosophy of Biological and Biomedical Sciences 42(4): 542–544.
Greek, R., N. Shanks, and M.J. Rice. 2011. The history and implications of testing thalidomide on animals. The Journal of Philosophy, Science & Law 11. http://jpsl.org/archives/history-and-implications-testing-thalidomide-animals/. Accessed August 5, 2014.
Shanks, N., and R. Greek. 2008. Experimental use of nonhuman primates is not a simple problem. Nature Medicine 14(10): 807–808.
Shanks, N., and R. Greek. 2009. Animal models in light of evolution. Boca Raton: Brown Walker.
Shanks, N., R. Greek, and J. Greek. 2009. Are animal models predictive for humans? Philosophy, Ethics, and Humanities in Medicine 4: 2. doi:10.1186/1747-5341-4-2.
Greek, R. 2012. Animal models and the development of an HIV vaccine. Journal of AIDS & Clinical Research S8: 001. doi:10.4172/2155-6113.S8-001.
Greek, R. 2012. Review of Zoobiquity: What animals can teach us about health and the science of healing, by B. Natterson-Horowitz and K. Bowers. Animals 2(4): 559–563.
Greek, R., A. Menache, and M.J. Rice. 2012. Animal models in an age of personalized medicine. Personalized Medicine 9(1): 47–64.
Greek, R., A. Pippus, and L.A. Hansen. 2012. The Nuremberg Code subverts human health and safety by requiring animal modeling. BMC Medical Ethics 13: 16. doi:10.1186/1472-6939-13-16.
Greek, R., and M.J. Rice. 2012. Animal models and conserved processes. Theoretical Biology and Medical Modelling 9: 40. doi:10.1186/1742-4682-9-40.
Greek, R. 2013. Animal models of cancer in light of evolutionary biology and complexity science. In The research and biology of cancer. Hong Kong: iConcept Press Ltd.
Greek, R. 2013. Animal models in drug development. In New insights into toxicity and drug testing, ed. Sivakumar Gowder, 124–152. Manhattan: InTech.
Greek, R., and L.A. Hansen. 2013. The strengths and limits of animal models as illustrated by the discovery and development of antibacterials. Biological Systems 2: 2. doi:10.4172/BSO.1000109.
Greek, R., and L.A. Hansen. 2013. Questions regarding the predictive value of one evolved complex adaptive system for a second: Exemplified by the SOD1 mouse. Progress in Biophysics and Molecular Biology 113: 231–253.
Greek, R., and A. Menache. 2013. Systematic reviews of animal models: Methodology versus epistemology. International Journal of Medical Sciences 10: 206–221.
Jones, R.C., and R. Greek. 2013. A review of the Institute of Medicine’s analysis of using chimpanzees in biomedical research. Science and Engineering Ethics 20: 481–504.
Curry, S.H. 2003. Why have so many drugs with stellar results in laboratory stroke models failed in clinical trials? A theory based on allometric relationships. Annals of the New York Academy of Sciences 993: 69–74.
Macleod, M. 2004. Systematic review and meta-analysis of experimental stroke. International Journal of Neuroprotection and Neuroregeneration 1: 9–12.
Kaste, M. 2005. Use of animal models has not contributed to development of acute stroke therapies: Pro. Stroke 36(10): 2323–2324.
O’Collins, V.E., M.R. Macleod, G.A. Donnan, L.L. Horky, B.H. van der Worp, and D.W. Howells. 2006. 1,026 experimental treatments in acute stroke. Annals of Neurology 59(3): 467–477.
Sena, E., H.B. van der Worp, D. Howells, and M. Macleod. 2007. How can we improve the pre-clinical development of drugs for stroke? Trends in Neurosciences 30(9): 433–439.
Ginsberg, M.D. 2008. Neuroprotection for ischemic stroke: Past, present and future. Neuropharmacology 55(3): 363–389.
Feuerstein, G.Z., and J. Chavez. 2009. Translational medicine for stroke drug discovery: The pharmaceutical industry perspective. Stroke 40: S121–S125.
Sena, E.S., H.B. van der Worp, P.M.W. Bath, D.W. Howells, and M.R. Macleod. 2010. Publication bias in reports of animal stroke studies leads to major overstatement of efficacy. PLoS Biology 8(3): e1000344.
O’Collins, V.E., M.R. Macleod, S.F. Cox, L. van Raay, E. Aleksoska, G.A. Donnan, and D.W. Howells. 2011. Preclinical drug evaluation for combination therapy in acute stroke using systematic review, meta-analysis, and subsequent experimental testing. Journal of Cerebral Blood Flow and Metabolism 31(3): 962–975.
Editorial. 2007. Cold shower for AIDS vaccines. Nature Medicine 13(12):1389–1390.
Buchbinder, S.P., D.V. Mehrotra, A. Duerr, et al. 2008. Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the step study): A double-blind, randomised, placebo-controlled, test-of-concept trial. Lancet 372: 1881–1893.
Gamble, L.J., and Q.L. Matthews. 2010. Current progress in the development of a prophylactic vaccine for HIV-1. Drug Design, Development and Therapy 5(9–26): 33.
Chu, B.C., C.C. Fan, and S.B. Howell. 1981. Activity of free and carrier-bound methotrexate against transport-deficient and high dihydrofolate dehydrogenase-containing methotrexate-resistant L1210 cells. Journal of the National Cancer Institute 66: 121–124.
Greenstein, J.P. 1954. Biochemistry of cancer, 2nd ed. New York: Academic Press.
Janofsky, M. 1993. On cigarettes, health and lawyers. New York Times, December 6. http://www.nytimes.com/1993/12/06/business/on-cigarettes-health-and-lawyers.html. Accessed April 17, 2014.
Lindsay, M.A. 2005. Finding new drug targets in the 21st century. Drug Discovery Today 10: 1683–1687.
Northrup, E. 1957. Science looks at smoking: A new inquiry into the effects of smoking on your health. New York: Coward-McCann.
Utidjian, M. 1988. The interaction between epidemiology and animal studies in industrial toxicology. In Perspectives in basic and applied toxicology, ed. B. Ballantyne, 309–329. London: Butterworth-Heinemann.
Gardner, Leroy U. 1938. Etiology of pneumoconiosis. Journal of the American Medical Association 111: 1925–1936.
Gross, P. 1977. The biologic response to inhaled mineral fibers: Facts and fancies. Reviews on Environmental Health 2(3): 167–175.
Muhle, H., and F. Pott. 2000. Asbestos as reference material for fibre-induced cancer. International Archives of Occupational and Environmental Health 73: S53–S59.
Oberdorster, G. 1996. Evaluation and use of animal models to assess mechanisms of fibre carcinogenicity. IARC Scientific 140: 107–125.
Smith, W.E., L. Miller, R.E. Elsasser, and D.D. Hubert. 1965. Tests for carcinogenicity of asbestos. Annals of the New York Academy of Sciences 132(1): 456–488.
Wagner, J.C. 1963. Asbestosis in experimental animals. British Journal of Industrial Medicine 20: 1–12.
Wagner, J.C., G. Berry, J.W. Skidmore, and V. Timbrell. 1974. The effects of the inhalation of asbestos in rats. British Journal of Cancer 29(3): 252–269.
KMR Group. 2012. R&D performance. http://www.kmrgroup.com/PressReleases/2012_08_08KMRPBFSuccessRate&CycleTimePressRelease.pdf. Accessed July 12, 2013.
Heywood, R. 1981. Target organ toxicity. Toxicology Letters 8(6): 349–358.
Eason, C.T., F.W. Bonner, and D.V. Parke. 1990. The importance of pharmacokinetic and receptor studies in drug safety evaluation. Regulatory Toxicology and Pharmacology 11(3): 288–307.
Lin, J.H. 1995. Species similarities and differences in pharmacokinetics. Drug Metabolism and Disposition 23(10): 1008–1021.
Li, A.P. 2004. Accurate prediction of human drug toxicity: A major challenge in drug development. Chemico-Biological Interactions 150: 3–7.
Geerts, H. 2009. Of mice and men: Bridging the translational disconnect in CNS drug discovery. CNS Drugs 23(11): 915–926.
Collins, F.S. 2011. Reengineering translational science: The time is right. Science Translational Medicine 3(90):90cm17. doi:10.1126/scitranslmed.3002747.
Giri, S., and A. Bader. 2011. Foundation review: Improved preclinical safety assessment using micro-BAL devices: The potential impact on human discovery and drug attrition. Drug Discovery Today 16: 382–397.
van Meer, P.J.K., M. Kooijman, C.C. Gispen-de Wied, E.H.M. Moors, and H. Schellekens. 2012. The ability of animal studies to detect serious post marketing adverse events is limited. Regulatory Toxicology and Pharmacology 64(3): 345–349.
Greek, R., and J. Greek. 2010. Is the use of sentient animals in basic research justifiable? Philosophy, Ethics, and Humanities in Medicine 5: 14. doi:10.1186/1747-5341-5-14.
Begley, S. 2003. Physician-researchers needed to get cures out of rat’s cage. Wall Street Journal, April 25. http://online.wsj.com/news/articles/SB105121836549788500.
Contopoulos-Ioannidis, D.G., E. Ntzani, and J.P. Ioannidis. 2003. Translation of highly promising basic science research into clinical applications. American Journal of Medicine 114(6): 477–484.
Crowley Jr., W.F. 2003. Translation of basic research into useful treatments: How often does it occur? American Journal of Medicine 114(6): 503–505.
Editorial. 2010. Hope in translation. Nature 467(7315):499.
Editorial. 2012. Must try harder. Nature 483(7391):509.
Hackam, D.G., and D.A. Redelmeier. 2006. Translation of research evidence from animals to humans. Journal of the American Medical Association 296(14): 1731–1732.
Johnston, S.C. 2006. Translation: Case study in failure. Annals of Neurology 59(3): 447–448.
Leslie, M. 2010. Biomedical research: Immunology uncaged. Science 327(5973): 1573.
Mankoff, S.P., C. Brander, S. Ferrone, and F.M. Marincola. 2004. Lost in translation: Obstacles to translational medicine. Journal of Translational Medicine 2: 14. doi:10.1186/1479-5876-2-14.
Marincola, F.M. 2003. Translational medicine: A two-way road. Journal of Translational Medicine 1: 1. doi:10.1186/1479-5876-1-1.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Greek, R. Letter to the Editor. Theor Med Bioeth 35, 389–394 (2014). https://doi.org/10.1007/s11017-014-9305-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11017-014-9305-5